Suven Life Sciences Ltd vs Unihealth Hospitals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Suven Life Sciences Ltd is ₹ 261.8 as of 23 Oct 15:30 . The P/E Ratio of Suven Life Sciences Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Unihealth Hospitals Ltd changed from 20.2 on March 2024 to 22 on March 2026 . This represents a CAGR of 2.89% over 3 years The Market Cap of Suven Life Sciences Ltd changed from ₹ 896.07 crore on March 2021 to ₹ 3503 crore on March 2026 . This represents a CAGR of 25.51% over 6 yearsThe Market Cap of Unihealth Hospitals Ltd changed from ₹ 207.9 crore on March 2024 to ₹ 568.97 crore on March 2026 . This represents a CAGR of 39.88% over 3 years The revenue of Suven Life Sciences Ltd for the Jun '26 is ₹ 11.09 crore as compare to the Mar '26 revenue of ₹ 8.3 crore. This represent the growth of 33.61% The revenue of Unihealth Hospitals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Suven Life Sciences Ltd for the Jun '26 is ₹ -124 crore as compare to the Mar '26 ebitda of ₹ -43.86 crore. This represent the growth of 184.95% The ebitda of Unihealth Hospitals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Suven Life Sciences Ltd changed from ₹ -28.04 crore to ₹ -127 crore over 9 quarters. This represents a CAGR of 96.11% The net profit of Unihealth Hospitals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Suven Life Sciences Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Unihealth Hospitals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Suven Life Sciences Ltd

Suven Life Sciences Limited, formerly known as Suven Pharmaceuticals Limited was incorporated in March, 1989.
The Company changed its name from Suven Pharmaceuticals Limited to Suven Life Sciences Limited in September, 2003.
Promoted by Venkateswarlu Jasti, Company began its operations in 1989 as specialty chemicals provider. The Company is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders.
Suven has a wholly owned subsidiary, Suven Neurosciences, Inc., USA, focused on clinical development activities of Suven molecules from phase 2, Proof-of-Concept (POC) studies. The Company is in the business of Contract Research And Manufacturing Services (CRAMS), catering to the needs of global life science industry and fine chemical majors.

About Unihealth Hospitals Ltd

Unihealth Consultancy Limited was incorporated as Private Limited Company under the name 'Unihealth Consultancy Private Limited', Certificate of Incorporation was issued by the Registrar of Companies, Mumbai on February 26, 2010.
The Company status changed to Public Limited, and its name was changed to 'Unihealth Consultancy Limited' dated April 26, 2023 issued by the Registrar of Companies, Mumbai. Unihealth Consultancy Limited is the Holding Company of the Group providing healthcare consultancy and management services.
The Company facilitates medical value travel for patients travelling from various countries into Middle East and Africa to India for advanced medical care services.
The Company is a healthcare service provider based out of Mumbai, India having operational presence in multiple countries across the African continent.

FAQs for the comparison of Suven Life Sciences Ltd and Unihealth Hospitals Ltd

Which company has a larger market capitalization, Suven Life Sciences Ltd or Unihealth Hospitals Ltd?

Market cap of Suven Life Sciences Ltd is 7,397 Cr while Market cap of Unihealth Hospitals Ltd is 787 Cr

What are the key factors driving the stock performance of Suven Life Sciences Ltd and Unihealth Hospitals Ltd?

The stock performance of Suven Life Sciences Ltd and Unihealth Hospitals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Suven Life Sciences Ltd and Unihealth Hospitals Ltd?

As of October 25, 2026, the Suven Life Sciences Ltd stock price is INR ₹261.8. On the other hand, Unihealth Hospitals Ltd stock price is INR ₹495.5.

How do dividend payouts of Suven Life Sciences Ltd and Unihealth Hospitals Ltd compare?

To compare the dividend payouts of Suven Life Sciences Ltd and Unihealth Hospitals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.